Reporter Bioassays

The VEGF Bioassay is a bioluminescent cell-based assay that measures VEGF stimulation and inhibition of KDR (VEGFR-2) using NFAT-RE as a readout. T...

The VEGF Bioassay is a bioluminescent cell-based assay that measures VEGF stimulation and inhibition of KDR (VEGFR-2) using NFAT-RE as a readout. T...

The VEGF Bioassay is a bioluminescent cell-based assay that measures VEGF stimulation and inhibition of KDR (VEGFR-2) using NFAT-RE as a readout. T...

TIM-3 (CD366, HAVCR2) is an immune checkpoint receptor expressed on a subset of activated T cells, regulatory T cells (Tregs), macrophages and dend...

TIM-3 (CD366, HAVCR2) is an immune checkpoint receptor expressed on a subset of activated T cells, regulatory T cells (Tregs), macrophages and dend...

TIM-3 (CD366, HAVCR2) is an immune checkpoint receptor expressed on a subset of activated T cells, regulatory T cells (Tregs), macrophages and dend...

TIGIT is an immune checkpoint protein expressed on lymphocytes. Highest expression levels are observed on CD4+ and CD8+ T cells, regulatory T cells...

Measure potency and stability of biologics designed to block the TIGIT/CD155 interaction.

TIGIT is an immune checkpoint protein expressed on lymphocytes. Highest expression levels are observed on CD4+ and CD8+ T cells, regulatory T cells...

TIGIT Negative Cells are control cells for use with the TIGIT/CD155 Blockade Bioassay.

LAG-3 is an immune checkpoint receptor expressed on activated CD4+ and CD8+ T cells and natural killer (NK) cells, and plays a critical role in reg...

Immunotherapy strategies aimed at inducing, strengthening or engineering T cell responses have emerged as promising approaches for the treatment of...

The T Cell Activation Bioassay, Propagation Model, provides a biologically relevant and specific MOA-based measure of TCR/CD3 Effector Cells withou...

Immunotherapy strategies aimed at inducing, strengthening or engineering T cell responses have emerged as promising approaches for the treatment of...

The T Cell Activation Bioassay, Propagation Model, provides a biologically relevant and specific MOA-based measure of TCR/CD3 Effector Cells withou...

Immunotherapy strategies aimed at inducing, strengthening or engineering T cell responses have emerged as promising approaches for the treatment of...

Immunotherapy strategies aimed at inducing, strengthening or engineering T cell responses have emerged as promising approaches for the treatment of...

Recombinant VEGF may be used as a positive control ligand in the VEGF Bioassay (Cat.# GA2001, GA2005). Human VEGF-165, amino acids Ala27-Arg191 (Ac...

Receptor activator of nuclear factor-κB (NF-κB; RANK/TRANCE receptor/TNFRSF11A) is a member of the tumor necrosis factor receptor (TNFR) family. Bi...

Receptor activator of nuclear factor-κB (NF-κB; RANK/TRANCE receptor/TNFRSF11A) is a member of the tumor necrosis factor receptor (TNFR) family. Bi...

Receptor activator of nuclear factor-κB (NF-κB; RANK/TRANCE receptor/TNFRSF11A) is a member of the tumor necrosis factor receptor (TNFR) family. Bi...

PD-1 is an immune inhibitory receptor expressed on activated T cells and B cells and plays a critical role in regulating immune responses to tumor ...

PD-1 is an immune inhibitory receptor expressed on activated T cells and B cells and plays a critical role in regulating immune responses to tumor ...

PD-1+TIGIT Combination Bioassay, Propagation Model, is a biologically relevant MOA-based assay that can be used to measure potency and stability o...